BaHammam Ahmed S, Pandi-Perumal Seithikurippu R, Piper Amanda, Bahammam Salman A, Almeneessier Aljohara S, Olaish Awad H, Javaheri Shahrokh
The University Sleep Disorders Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
J Sleep Res. 2016 Aug;25(4):445-53. doi: 10.1111/jsr.12400. Epub 2016 Mar 18.
The role of gender and menopause in obstructive sleep apnoea is well known; however, no study has reported the impact of gender on the clinical presentation and the nocturnal respiratory events in patients with obesity hypoventilation syndrome. Therefore, this study prospectively evaluated differences in the clinical characteristics of women and men with obesity hypoventilation syndrome in a large cohort of patients with obstructive sleep apnoea. During the study period, a total of 1973 patients were referred to the sleep clinic with clinical suspicion of obstructive sleep apnoea. All patients underwent overnight polysomnography, during which time spirometry, arterial blood samples and thyroid tests were routinely obtained. Among 1973 consecutive patients, 1693 (617 women) were diagnosed with obstructive sleep apnoea, among whom 144 suffered from obesity hypoventilation syndrome (96 women). The prevalence of obesity hypoventilation syndrome among women and men was 15.6% and 4.5%, respectively (P < 0.001). Women with obesity hypoventilation syndrome were significantly older than men with obesity hypoventilation syndrome (61.5 ± 11.9 years versus 49.1 ± 12.5 years, P < 0.001). Although there were no significant differences between genders regarding symptoms, body mass index, spirometric data or daytime PaCO2 , women with obesity hypoventilation syndrome suffered significantly more from hypertension, diabetes and hypothyroidism. The prevalence of obesity hypoventilation syndrome was higher in post-menopausal (21%) compared with pre-menopausal (5.3%) women (P < 0001). HCO3 and duration of SpO2 <90% were the only independent predictors of obesity hypoventilation syndrome. In conclusion, this study reported that among subjects referred to the sleep disorders clinic for evaluation of obstructive sleep apnoea, obesity hypoventilation syndrome is more prevalent in women than men, and that women with obesity hypoventilation syndrome suffer from significantly more co-morbidities. Post-menopausal women with obstructive sleep apnoea have the highest prevalence of obesity hypoventilation syndrome.
性别和更年期在阻塞性睡眠呼吸暂停中的作用已广为人知;然而,尚无研究报告性别对肥胖低通气综合征患者临床表现和夜间呼吸事件的影响。因此,本研究前瞻性评估了一大群阻塞性睡眠呼吸暂停患者中肥胖低通气综合征女性和男性临床特征的差异。在研究期间,共有1973例临床怀疑患有阻塞性睡眠呼吸暂停的患者被转诊至睡眠诊所。所有患者均接受了整夜多导睡眠监测,在此期间常规采集肺量计、动脉血样本和甲状腺检查数据。在1973例连续患者中,1693例(617例女性)被诊断为阻塞性睡眠呼吸暂停,其中144例患有肥胖低通气综合征(96例女性)。肥胖低通气综合征在女性和男性中的患病率分别为15.6%和4.5%(P<0.001)。肥胖低通气综合征女性的年龄显著高于肥胖低通气综合征男性(61.5±11.9岁对49.1±12.5岁,P<0.001)。尽管在症状、体重指数、肺量计数据或日间动脉血二氧化碳分压方面两性之间无显著差异,但肥胖低通气综合征女性患高血压、糖尿病和甲状腺功能减退的情况明显更多。绝经后女性(21%)肥胖低通气综合征的患病率高于绝经前女性(5.3%)(P<0.001)。碳酸氢根和血氧饱和度<90%的持续时间是肥胖低通气综合征的唯一独立预测因素。总之,本研究报告称,在因阻塞性睡眠呼吸暂停评估而转诊至睡眠障碍诊所的受试者中,肥胖低通气综合征在女性中比男性更普遍,且肥胖低通气综合征女性患合并症的情况明显更多。患有阻塞性睡眠呼吸暂停的绝经后女性肥胖低通气综合征的患病率最高。